|
1
|
McMillan RL: Coronary atherosclerotic
heart disease. N C Med J. 19:147–149. 1958.PubMed/NCBI
|
|
2
|
Hansson GK: Inflammation, atherosclerosis,
and coronary artery disease. N Engl J Med. 352:1685–1695. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kaperonis EA, Liapis CD, Kakisis JD,
Dimitroulis D and Papavassiliou VG: Inflammation and
atherosclerosis. Eur J Vasc Endovasc Surg. 31:386–393. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stoll G and Bendszus M: Inflammation and
atherosclerosis: Novel insights into plaque formation and
destabilization. Stroke. 37:1923–1932. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cannon JG: Inflammatory cytokines in
nonpathological states. News Physiol Sci. 15:298–303.
2000.PubMed/NCBI
|
|
6
|
Barlic J and Murphy PM: Chemokine
regulation of atherosclerosis. J Leukoc Biol. 82:226–236. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Abel S, Hundhausen C, Mentlein R, Schulte
A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S,
Muetze B, et al: The transmembrane CXC-chemokine ligand 16 is
induced by IFN-gamma and TNF-alpha and shed by the activity of the
disintegrin-like metalloproteinase ADAM10. J Immunol.
172:6362–6372. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shimaoka T, Kume N, Minami M, Hayashida K,
Kataoka H, Kita T and Yonehara S: Molecular cloning of a novel
scavenger receptor for oxidized low density lipoprotein, SR-PSOX,
on macrophages. J Biol Chem. 275:40663–40666. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schreyer SA, Vick CM and LeBoeuf RC: Loss
of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces
atherosclerosis in mice. J Biol Chem. 277:12364–12368. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nowaczenko M, Sarzyńska-Długosz I and
Członkowska A: Prevalence of carotid arteries atherosclerotic
changes in ischemic stroke patients. Neurol Neurochir Pol.
37:27–36. 2003.(In Polish). PubMed/NCBI
|
|
11
|
Smith C, Halvorsen B, Otterdal K, Waehre
T, Yndestad A, Fevang B, Sandberg WJ, Breland UM, Frøland SS, Oie
E, et al: High levels and inflammatory effects of soluble CXC
ligand 16 (CXCL16) in coronary artery disease:down-regulatory
effects of statins. Cardiovasc Res. 79:195–203. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Agostini C, Cabrelle A, Calabrese F,
Bortoli M, Scquizzato E, Carraro S, Miorin M, Beghè B, Trentin L,
Zambello R, et al: Role for CXCR6 and its ligand CXCL16 in the
pathogenesis of T-cell alveolitis in sarcoidosis. Am J Respir Crit
Care Med. 172:1290–1298. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Minami M, Kume N, Shimaoka T, Kataoka H,
Hayashida K, Yonehara S and Kita T: Expression of scavenger
receptor for phosphatidylserine and oxidized lipoprotein (SR-PSOX)
in human atheroma. Ann N Y Acad Sci. 947:373–376. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhuge X, Murayama T, Arai H, Yamauchi R,
Tanaka M, Shimaoka T, Yonehara S, Kume N, Yokode M and Kita T:
CXCL16 is a novel angiogenic factor for human umbilical vein
endothelial cells. Biochem Biophys Res Commun. 331:1295–1300. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aslanian AM and Charo IF: Targeted
disruption of the scavenger receptor and chemokine CXCL16
accelerates atherosclerosis. Circulation. 114:583–590. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wuttge DM, Zhou X, Sheikine Y, Wågsäter D,
Stemme V, Hedin U, Stemme S, Hansson GK and Sirsjö A:
CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and
scavenger receptor expressed in atherosclerotic lesions.
Arterioscler Thromb Vasc Biol. 24:750–755. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu T, Xie C, Wang HW, Zhou XJ, Schwartz N,
Calixto S, Mackay M, Aranow C, Putterman C and Mohan C: Elevated
urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC
chemokine ligand 16 in multiple murine lupus strains and human
lupus nephritis. J Immunol. 179:7166–7175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Carswell EA, Old LJ, Kassel RL, Green S,
Fiore N and Williamson B: An endotoxin-induced serum factor that
causes necrosis of tumors. Proc Natl Acad Sci USA. 72:pp.
3666–3670. 1975; View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang YN, Che SM and Ma AQ: Clinical
significance of serum cytokines IL-1beta, sIL-2R, IL-6, TNF-alpha,
and IFN-γ in acute coronary syndrome. Chin Med Sci J. 19:120–124.
2004.PubMed/NCBI
|
|
20
|
Trepels T, Zeiher AM and Fichtlscherer S:
Acute coronary syndrome and inflammation. Biomarkers for
diagnostics and risk stratification. Herz. 29:769–776. 2004.(In
German).
|
